Back to search

University of Edinburgh

Exploring the mechanism by which genetic variation at chr19q13 imparts elevated risk of colorectal cancer: the interaction of mucosal expression of FUT2, plasma vitamin B12 level and the intestinal microbiome

Abstract

dc:description.abstract

Genome-wide association studies (GWAS) established that genetic variation at chr19q13.33 causally influences colorectal cancer (CRC) risk with each risk allele (rs601338) imparting 7% greater risk of CRC (OR 1.07, P=6.11x10⁻¹⁰). Variation at this locus influences abundance of the gene FUT2. Expressed in intestinal epithelial cells, FUT2 encodes a fucosyltransferase enzyme that regulates α-1,2 glycosylation. These fucosylated glycans act as attachment sites and nutrient sources for certain bacteria, thus FUT2 polymorphisms may influence intestinal microbiome. In addition, through multiple worldwide GWAS, non-functional FUT2 alleles are known to be associated with elevated plasma vitamin B12 concentrations. This thesis investigates the inter-relationships of FUT2 genotype, gene expression, vitamin B12, and the intestinal microbiome in the context of CRC pathogenesis, integrating evidence from human genetic analyses, experimental mouse models and clinical studies in human subjects. Using summary-data-based Mendelian Randomisation, eQTLs were leveraged for FUT2 expression in colon tissue (GTEx) and GWAS data for plasma B12 (Generation Scotland) to dissect causal pathways. FUT2 expression was strongly and significantly inversely associated with predicted plasma B12-levels (b;-0.735 [SE]=0.110, P=2.63x10⁻¹¹) and with CRC-risk (b;-0.256 [SE]=0.058, P=5.85x10⁻⁵). Mediation analysis revealed that 80% of the effect of FUT2 on CRC risk was explained by plasma B12, implicating B12 as a central mediator of risk. Stool samples and aligned clinical data were obtained from 20 CRC patients and 20 matched controls from whom concurrent shotgun faecal metagenomic sequencing of stool and rectal biopsies, plasma B12 measurement, and FUT2 genotypes were analysed. These analyses identified significant differences between groups segregated by genotype, cancer status and plasma B12-associated differences in the relative abundance of over 25 bacterial taxa, consistent with an intestinal microbiome-mediated mechanism. To explore putative causal relationships, mouse modelling experiments were conducted in parallel. No colorectal tumours arose in Fut2 knockout (Fut2⁻/⁻) and wild-type (Fut2⁺/⁺) control mice or those fed B12 supplementation alone, consistent with loss of Fut2 being insufficient alone for tumorigenesis. However, Fut2⁻/⁻ mice administered the chemical carcinogens azoxymethane/dextran sodium sulphate (AOM/DSS) exhibited a significantly higher tumour burden than Fut2⁺/⁺AOM/DSS mice (6.37 v 2.85 (p=0.02)). Notably, B12 supplementation of Fut2⁺/⁺AOM/DSS mice increased the tumour burden (6.48 v 2.85, p=0.009), equivalent to the burden in Fut2⁻/⁻AOM/DSS mice, consistent with B12 supplementation mirroring the loss of Fut2. Whilst faecal transplant alone increased tumour burden in Fut2⁺/⁺/AOM/DSS mice (2.85 v 4.89, p=0.013), Fut2⁻/⁻/AOM/DSS mice receiving faecal transplant from Fut2⁻/⁻ mice substantially increased tumour burden score (6.38 v 10.22, p=0.046). These findings provide functional evidence that B12 metabolism and the Fut2-associated intestinal microbiome potentially synergistically influence colorectal neoplasia (CRN) progression. Collectively, this body of work establishes vitamin B12 as a critical mediator of FUT2-associated CRC risk and highlights the gut microbiome as a plausible mechanistic link. Importantly, these findings suggest that genetic and microbial biomarkers may guide precision chemoprevention, including potential therapeutic strategies aimed at modulating plasma B12 levels or microbiome composition in genetically susceptible individuals, particularly those who are non-secretors of FUT2.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Morven, Allan
Advisors dc:contributor.advisor
  • Dunlop, Malcolm
  • Myant, Kevin
  • Farrington, Susan

Subjects

dc:subject × 5

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
University of Edinburgh
Base URL
era.ed.ac.uk/server/oai/request
Last updated
2026-11-21
Source record
OAI-PMH GetRecord
citation

Morven, Allan. Exploring the mechanism by which genetic variation at chr19q13 imparts elevated risk of colorectal cancer: the interaction of mucosal expression of FUT2, plasma vitamin B12 level and the intestinal microbiome. 2026. https://hdl.handle.net/1842/45549